This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ICON Opens Purpose-Built, Hospital Based Translational Medicine Unit In Manchester

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.

The two-floor, 34-bed hospital-based unit brings ICON’s Phase I global bed capacity to over 280 beds, and includes a sample handling laboratory, 24-hour medical cover, local GMP pharmacy, contiguous access to the Accident and Emergency department at the Manchester Royal Infirmary and local bioanalytical support. The unit also features four fully environmentally controlled pharmacodynamic testing suites where ICON continues its industry-leading work modelling complex pathologies to identify early efficacy signals of compounds in clinical areas such as Neuropathic Pain, Anxiety and Cognitive Degeneration.

Alan Morgan, ICON Group President – Early Clinical Research, commented: “ICON has conducted clinical pharmacology studies in Manchester for over 25 years, and the opening of this translational medicine unit further demonstrates our commitment to streamlining the process that guides new compounds through the early phases of development into treatments that improve human health. Our collaborative relationship with the CMFT, and the location of the new unit on one of the largest teaching hospitals in the UK, facilitates unrivalled access to the expertise, specialist procedures and patient populations necessary to bring life saving medicines to market faster.”

CMFT is a member of the Manchester Academic Health Science Centre (MAHSC), which is one of only five such sites in the UK designated by the Department of Health as a centre of excellence in applying health research and education into healthcare. Through the collaboration, ICON shares expertise with academic and medical communities of this network and has access to the facilities of other NHS members and the University of Manchester.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
ICLR $81.48 0.84%
AAPL $118.44 -2.36%
FB $94.14 0.14%
GOOG $631.21 0.90%
TSLA $259.99 -2.31%


Chart of I:DJI
DOW 17,598.20 -91.66 -0.52%
S&P 500 2,098.04 -5.80 -0.28%
NASDAQ 5,115.3820 -12.8990 -0.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs